Joint health: synovial inflammation degrades cartilage
it is about choice - by both physicians and patients for the Orals to manage weight over other routes (like injectables) - period Not surprising that both Novo and Lilly are going all in - Spending on Promotions, Investing in manufacturing Units to meet global demand admidst tariff wars and being bold by keeping a prelaunch stock of over $1.5 B even before the FDA approval Source - Truveta , IQVIA , IMS , cafepharma, Forbes To view or add a comment, sign in The real risk isnt the drug
However, several research studies and clinical observations provide preliminary insights into their potential efficacy
Should you be prescribed Semaglutide GLP-1 or similar medications, our team will guide you through your treatment, ensuring you understand your medication and feel supported throughout your journey to wellness
Patients who follow the recommended titration schedule provided by their healthcare provider and remain consistent with it tend to see better results